BioCentury
ARTICLE | Clinical News

ImClone regulatory update

October 9, 1995 7:00 AM UTC

The New York company received notice of allowance for a European patent covering its Repair Chain Reaction (RCR) DNA probe technology, which allows for rapid amplification and detection of DNA targets...